GO:0070292 N-acylphosphatidylethanolamine metabolic process: Endocannabinoid Precursor Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070292 describes the chemical reactions and pathways involving N-acylphosphatidylethanolamines (NAPEs), which are phosphatidylethanolamine lipids acylated at the nitrogen headgroup.
• NAPE metabolism is best known as the source of N-acylethanolamines (NAEs), including the endocannabinoid anandamide, through the action of NAPE-hydrolyzing phospholipase D (NAPE-PLD) [1,6].
• The pathway is initiated by N-acyltransferase (NAT) enzymes that transfer an acyl chain from phosphatidylcholine to phosphatidylethanolamine, forming NAPE.
• NAPE and its metabolites are linked to dietary fat handling, obesity, hepatic steatosis, and intestinal metabolic adaptation.
• Beyond endocannabinoid signaling, NAPE has been implicated in cellular lactate homeostasis, revealing new metabolic roles for this unusual triply acylated phospholipid.
• NAPE metabolism can be studied with fluorescence-based NAPE-PLD activity assays, NAT activity assays, and genetic models in organisms such as Caenorhabditis elegans [3,4,7].
Description
N-acylphosphatidylethanolamine (NAPE) is a unique class of phospholipid in which the nitrogen of phosphatidylethanolamine carries an additional acyl chain. The Gene Ontology term GO:0070292, N-acylphosphatidylethanolamine metabolic process, captures the chemical reactions and pathways that produce, modify, and break down these lipids. Interest in this pathway stems largely from the fact that NAPE is the immediate precursor of N-acylethanolamines (NAEs), a family of signaling lipids that includes the endocannabinoid anandamide [1,6]. Because NAEs regulate pain, appetite, inflammation, and energy balance, the enzymes that build and degrade NAPE are considered attractive drug targets. The pathway begins when a membrane-bound N-acyltransferase transfers an acyl group from a donor phospholipid to phosphatidylethanolamine, generating NAPE. NAPE can then be hydrolyzed by NAPE-hydrolyzing phospholipase D (NAPE-PLD) to release NAEs and phosphatidic acid [1,6]. This two-step sequence places NAPE metabolism at the intersection of lipid biosynthesis and endocannabinoid signaling. Recent work has also shown that NAPE itself may have signaling or metabolic functions beyond serving as a precursor, including a role in lactate homeostasis. For researchers, GO:0070292 provides a structured framework for annotating genes and proteins involved in NAPE turnover. The pathway is conserved from invertebrates to mammals, and model organisms such as C. elegans have been used to dissect its physiological roles. Neuronal activity, including glutamate stimulation, can rapidly increase NAPE and NAE formation in cortical neurons, indicating that this metabolic process is dynamically regulated. Understanding NAPE metabolism therefore has implications for neurobiology, metabolic disease, and lipid biochemistry [1,2,8].
N-acylphosphatidylethanolamine metabolic process At A Glance
| GO ID | GO:0070292 |
|---|---|
| GO term | N-acylphosphatidylethanolamine metabolic process |
| Ontology | biological_process |
| Synonym | N-acylphosphatidylethanolamine metabolism; NAPE metabolic process; NAPE metabolism |
| Definition | The chemical reactions and pathways involving N-acylphosphatidylethanolamines, which are phosphatidylethanolamines substituted at nitrogen by an acyl group. |
| Major function | Production and turnover of NAPE lipids, which serve as precursors for N-acylethanolamines including the endocannabinoid anandamide [1,6]. |
| Key enzymes | N-acyltransferase (NAT) and NAPE-hydrolyzing phospholipase D (NAPE-PLD) [4,6]. |
| Related molecules | Phosphatidylethanolamine, N-acylphosphatidylethanolamine, N-acylethanolamines, anandamide [1,6]. |
| Model organisms | Mus musculus, Caenorhabditis elegans [2,7]. |
What Is GO:0070292?
GO:0070292, N-acylphosphatidylethanolamine metabolic process, is defined as the chemical reactions and pathways involving N-acylphosphatidylethanolamines. An N-acylphosphatidylethanolamine is a phosphatidylethanolamine molecule in which the nitrogen atom of the ethanolamine headgroup is substituted with an acyl group. This term encompasses the biosynthesis of NAPE from phosphatidylethanolamine and an acyl donor, as well as the subsequent hydrolysis or further metabolism of NAPE [1,4,6]. Synonyms include N-acylphosphatidylethanolamine metabolism, NAPE metabolic process, and NAPE metabolism.
Why Is N-acylphosphatidylethanolamine metabolic process Important in Cell Biology?
NAPE metabolism is important because it controls the production of N-acylethanolamines, a class of lipid mediators that includes the endocannabinoid anandamide and related signaling molecules [1,6]. These lipids influence appetite, pain perception, inflammation, and energy metabolism, making the NAPE pathway a focal point for drug discovery. In addition, NAPE metabolism has been directly linked to dietary fat handling and metabolic disease: intestinal epithelial NAPE-PLD deletion alters metabolic adaptation to dietary fat and affects obesity and steatosis in mice. The pathway is also dynamically regulated by neuronal activity, as glutamate stimulates NAPE and NAE formation in cortical neurons. More recently, NAPE has been proposed to participate in lactate homeostasis, expanding its biological roles beyond endocannabinoid precursor function. Together, these findings make GO:0070292 relevant to neurobiology, metabolic disease, and lipid signaling research [1,2,5,8].
• NAPE is the immediate precursor of N-acylethanolamines, including the endocannabinoid anandamide, which regulates pain, mood, and appetite [1,6].
• NAPE-PLD, the enzyme that hydrolyzes NAPE, is a potential drug target for endocannabinoid-related disorders.
• Intestinal epithelial NAPE-PLD links dietary fat to metabolic adaptations in obesity and hepatic steatosis.
• Glutamate stimulation rapidly increases NAPE and NAE formation in cortical neurons, linking the pathway to neuronal activity.
• NAPE metabolism is conserved in C. elegans, providing a tractable genetic model for studying endocannabinoid-related enzymes.
• N-acyltransferases (NATs) that synthesize NAPE are key regulatory nodes in the pathway and can be assayed biochemically.
• Fluorescence-based NAPE-PLD activity assays enable quantitative measurement of enzyme function in vitro and in cells.
• NAPE has been implicated in lactate homeostasis, suggesting metabolic roles beyond lipid signaling.
• Dysregulation of NAPE metabolism may contribute to obesity, steatosis, and related metabolic disorders.
• The pathway provides a framework for annotating genes involved in lipid biosynthesis and endocannabinoid signaling.
What Happens During N-acylphosphatidylethanolamine metabolic process?
Biosynthesis of NAPE by N-acyltransferases
In simple terms: The first step is attaching an extra fatty acid chain to a common membrane lipid.
NAPE biosynthesis begins with the transfer of an acyl group from a donor phospholipid, typically phosphatidylcholine, to the nitrogen of phosphatidylethanolamine. This reaction is catalyzed by N-acyltransferase (NAT) enzymes, which are membrane-associated proteins. The resulting NAPE molecule is a triply acylated phospholipid, with acyl chains at the sn-1, sn-2, and N-position. NAT activity can be measured using biochemical assays that detect the formation of NAPE from radiolabeled or fluorescent substrates. The enzyme is thought to be regulated by calcium and other factors, although the precise mechanisms continue to be investigated.
Hydrolysis of NAPE by NAPE-PLD
In simple terms: A second enzyme cuts NAPE to release a signaling molecule and a lipid byproduct.
NAPE-hydrolyzing phospholipase D (NAPE-PLD) cleaves NAPE to produce N-acylethanolamines (NAEs) and phosphatidic acid [1,6]. This reaction is the principal route for the generation of anandamide and other NAEs in mammalian tissues. NAPE-PLD belongs to the metallo-beta-lactamase family and requires zinc for catalysis. Its activity can be quantified using fluorescence-based assays that monitor substrate conversion. Because NAPE-PLD controls the availability of endocannabinoids, it is a key regulatory point in the pathway.
Alternative routes and further metabolism of NAEs
In simple terms: There are other ways to make and break down these signaling lipids.
Although NAPE-PLD is the best-characterized NAPE-hydrolyzing enzyme, alternative pathways for NAE production have been proposed, including phospholipase C and phosphatase activities. Once formed, NAEs can be further metabolized by fatty acid amide hydrolase (FAAH) or other enzymes, terminating their signaling actions. The balance between NAPE synthesis and hydrolysis therefore determines the steady-state levels of NAEs. In C. elegans, genetic studies have helped define the enzymes involved in NAPE metabolism and their physiological roles.
Regulation by neuronal activity and dietary signals
In simple terms: The pathway can be switched on by nerve signals or changes in diet.
Glutamate stimulation of cortical neurons in culture rapidly increases the formation of NAPE and NAEs, indicating that neuronal activity can drive the pathway. This suggests that NAPE metabolism is not merely a housekeeping process but is dynamically coupled to synaptic signaling. In the intestine, NAPE-PLD expression links dietary fat intake to metabolic adaptations, and its deletion alters obesity and steatosis in mice. These findings highlight that NAPE metabolism responds to both neural and nutritional cues [2,8].
Emerging roles in lactate homeostasis
In simple terms: NAPE may also help cells manage lactate, a waste product of energy metabolism.
A recent study using photoaffinity labeling revealed that NAPE interacts with proteins involved in lactate homeostasis, suggesting a role for this lipid in cellular energy metabolism. This finding expands the known functions of NAPE beyond serving as a precursor for NAEs. The mechanism by which NAPE influences lactate levels is still under investigation, but it points to broader metabolic roles for this unusual phospholipid.
Key Genes Involved in GO:0070292 N-acylphosphatidylethanolamine metabolic process
The following genes and proteins are central to N-acylphosphatidylethanolamine metabolic process (GO:0070292) based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NAPE-PLD | Hydrolyzes NAPE to release N-acylethanolamines and phosphatidic acid [1,6] | Key enzyme for endocannabinoid biosynthesis; drug target |
| NAT (N-acyltransferase) | Catalyzes the formation of NAPE from phosphatidylethanolamine and an acyl donor | Rate-limiting enzyme for NAPE synthesis; assayable activity |
| FAAH | Degrades N-acylethanolamines such as anandamide | Regulates endocannabinoid tone downstream of NAPE metabolism |
| GDE1 | Alternative NAPE-hydrolyzing enzyme in some contexts | Contributes to NAE production through non-canonical routes |
| ABHD4 | May act as a phospholipase in NAPE metabolism | Potential alternative route for NAE synthesis |
| PLA2G | Phospholipase A2 enzymes can influence NAPE precursor pools | Modulates availability of phosphatidylethanolamine |
| CB1 receptor | Mediates effects of anandamide produced from NAPE | Target for neuropsychiatric and metabolic studies |
| CB2 receptor | Mediates effects of endocannabinoids in immune cells | Relevant to inflammation research |
| TRPV1 | Ion channel activated by anandamide and related NAEs | Links NAPE metabolism to pain signaling |
| PPAR-alpha | Nuclear receptor activated by NAEs, influencing lipid metabolism | Connects NAPE pathway to energy homeostasis |
| NAPE-PLD (C. elegans ortholog) | Conserved enzyme in invertebrate NAPE metabolism | Genetic model for endocannabinoid research |
| NAT (C. elegans ortholog) | Conserved N-acyltransferase for NAPE synthesis | Model for studying NAPE biosynthesis in vivo |
| FAAH (C. elegans ortholog) | Degrades NAEs in invertebrates | Comparative studies of endocannabinoid turnover |
| GPR55 | Putative cannabinoid receptor influenced by NAEs | Emerging target in metabolic and inflammatory research |
| GPR119 | Receptor activated by NAEs, involved in glucose homeostasis | Links NAPE metabolism to metabolic control |
| NAPE-PLD (mouse) | Enzyme studied in intestinal epithelial deletion models | Used to link dietary fat to obesity and steatosis |
| NAT (mouse) | Enzyme responsible for NAPE synthesis in mammalian tissues | Target for modulating NAPE levels in vivo |
| FAAH (mouse) | Enzyme that terminates NAE signaling | Model for endocannabinoid-related phenotypes |
How Is N-acylphosphatidylethanolamine metabolic process Regulated?
NAPE metabolism is regulated at multiple levels. Neuronal activity, such as glutamate stimulation, rapidly increases NAPE and NAE formation in cortical neurons, indicating activity-dependent regulation. Dietary fat intake influences the pathway in the intestine, where NAPE-PLD deletion alters metabolic adaptation to high-fat diets. The activity of NAPE-PLD and NAT enzymes can also be regulated by calcium, post-translational modifications, and membrane lipid composition, although the precise mechanisms are still being elucidated [4,6]. In C. elegans, genetic pathways controlling NAPE metabolism have been partially characterized, providing insights into conserved regulatory mechanisms.
N-acylphosphatidylethanolamine metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NAPE-PLD | Obesity and hepatic steatosis | Intestinal epithelial-specific knockout mouse |
| NAPE-PLD | Pain and neuropsychiatric disorders [1,6] | NAPE-PLD knockout mouse with behavioral testing |
| FAAH | Endocannabinoid-related disorders | FAAH knockout mouse |
| NAT | Metabolic dysregulation | NAT overexpression or knockout cell models |
| NAPE-PLD (C. elegans) | Conserved endocannabinoid functions | C. elegans mutants |
Obesity and hepatic steatosis
Intestinal epithelial NAPE-PLD links dietary fat to metabolic adaptations, and its deletion in mice affects obesity and steatosis. This suggests that NAPE metabolism is directly involved in whole-body energy balance and lipid storage. The pathway may therefore be a therapeutic target for metabolic disorders.
Neuropsychiatric and pain disorders
Because NAPE is the precursor of anandamide, which activates CB1 receptors and TRPV1 channels, altered NAPE metabolism could influence pain, anxiety, and mood [1,6]. Enzymes such as NAPE-PLD and FAAH are being explored as drug targets for these conditions. Glutamate-driven NAPE formation in neurons further supports a role in synaptic signaling.
Inflammatory and immune conditions
NAEs produced from NAPE can activate CB2 receptors and PPAR-alpha, which modulate inflammation and immune responses. Dysregulation of NAPE metabolism may therefore contribute to inflammatory diseases, although direct evidence in human patients is still limited.
Emerging metabolic roles
NAPE has been linked to lactate homeostasis, suggesting that its metabolic functions extend beyond endocannabinoid precursor activity. This could have implications for diseases involving altered energy metabolism, such as cancer and metabolic syndrome, but further research is needed.
From N-acylphosphatidylethanolamine metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NAPE-PLD affect dietary fat handling? | Intestinal epithelial NAPE-PLD knockout mouse |
| Does NAPE metabolism regulate neuronal NAE production? | Primary cortical neuron cultures with glutamate stimulation |
| Is NAPE involved in lactate homeostasis? | Photoaffinity labeling in cell lines with NAPE probes |
| What is the role of NAT in NAPE synthesis? | NAT overexpression or knockout in mammalian cells |
| How is NAPE-PLD activity regulated? | Fluorescence-based activity assays with purified enzyme |
| Are endocannabinoid enzymes conserved in invertebrates? | C. elegans genetic mutants |
How to Study the N-acylphosphatidylethanolamine metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence-based NAPE-PLD assay | NAPE-PLD hydrolytic activity | Enzyme kinetics and inhibitor screening |
| NAT activity assay | N-acyltransferase activity | Measuring NAPE biosynthesis |
| Lipidomics / mass spectrometry | Levels of NAPE and NAE species | Profiling pathway activity in tissues |
| Photoaffinity labeling | Protein interactions with NAPE | Identifying NAPE-binding proteins |
| Glutamate stimulation of neurons | Activity-dependent NAPE/NAE formation | Neuronal signaling studies |
| C. elegans genetics | Conserved gene functions | In vivo dissection of endocannabinoid enzymes |
| Mouse knockout models | Physiological roles of NAPE-PLD | Metabolic and behavioral phenotyping |
Fluorescence-based NAPE-PLD activity assay
This method measures the enzymatic hydrolysis of NAPE by NAPE-PLD using a fluorescent substrate, allowing quantitative assessment of enzyme activity in vitro or in cell lysates. It is useful for screening inhibitors or comparing mutant enzymes.
NAT activity assay
N-acyltransferase activity can be assayed by monitoring the transfer of radiolabeled or fluorescent acyl groups to phosphatidylethanolamine, producing NAPE. This assay is essential for studying the biosynthetic arm of the pathway.
Lipidomics and mass spectrometry
Mass spectrometry-based lipidomics can quantify NAPE and NAE species in biological samples, providing a snapshot of pathway activity. This approach is valuable for linking NAPE metabolism to physiological states.
Genetic models and behavioral assays
Knockout or transgenic models in mice and C. elegans allow researchers to test the physiological consequences of altered NAPE metabolism, including effects on feeding, pain, and metabolism [2,7].
How CRISPR Can Be Used to Study GO:0070292 N-acylphosphatidylethanolamine metabolic process
Knockout
CRISPR knockout of NAPE-PLD or NAT genes can eliminate enzyme activity, allowing researchers to test the consequences for NAPE and NAE levels [2,4]. For example, intestinal epithelial NAPE-PLD knockout in mice alters metabolic adaptation to dietary fat. Knockout cell lines provide a clean background for biochemical assays.
Point Mutation
Point mutations can be introduced into catalytic residues of NAPE-PLD or NAT to dissect their enzymatic mechanisms [3,4]. Such mutants help distinguish between catalytic activity and potential scaffolding functions. They are also useful for validating active-site residues identified in structural studies.
Knock-in
Knock-in of epitope tags or fluorescent reporters into endogenous NAPE-PLD or NAT loci enables real-time tracking of protein localization and expression [3,4]. Tagged knock-in models can be used to study tissue-specific expression and subcellular localization.
Overexpression
Overexpression of NAPE-PLD or NAT in cell lines can increase flux through the pathway, raising NAE levels and enabling downstream signaling studies [1,4]. This approach is useful for testing whether increased NAPE metabolism is sufficient to drive specific phenotypes.
How EDITGENE Supports N-acylphosphatidylethanolamine metabolic process Research
Researchers studying N-acylphosphatidylethanolamine metabolic process-related genes often need to determine whether a candidate gene is causally involved in lipid signaling, metabolic regulation, or disease. EDITGENE provides CRISPR-based cell models and screening services to accelerate this functional validation.
Contact EDITGENE today to design your custom CRISPR model for N-acylphosphatidylethanolamine metabolic process research.
Frequently Asked Questions About N-acylphosphatidylethanolamine metabolic process
What is N-acylphosphatidylethanolamine metabolic process?
It is the set of chemical reactions and pathways involving N-acylphosphatidylethanolamines (NAPEs), which are phosphatidylethanolamines with an acyl group attached to the nitrogen.
What is GO:0070292?
GO:0070292 is the Gene Ontology identifier for N-acylphosphatidylethanolamine metabolic process, a biological process term.
What genes are involved in N-acylphosphatidylethanolamine metabolic process?
Key genes include NAPE-PLD, which hydrolyzes NAPE, and N-acyltransferases (NATs), which synthesize NAPE [4,6].
What enzymes synthesize NAPE?
N-acyltransferases (NATs) catalyze the transfer of an acyl group from a donor phospholipid to phosphatidylethanolamine, forming NAPE.
What is the role of NAPE-PLD?
NAPE-PLD hydrolyzes NAPE to release N-acylethanolamines, including the endocannabinoid anandamide, and phosphatidic acid [1,6].
How is NAPE metabolism linked to obesity?
Intestinal epithelial NAPE-PLD deletion alters metabolic adaptation to dietary fat and affects obesity and steatosis in mice.
Is NAPE metabolism conserved in invertebrates?
Yes, components of the pathway are conserved in Caenorhabditis elegans, which is used as a genetic model.
How can I measure NAPE-PLD activity?
Fluorescence-based NAPE-PLD activity assays are available for quantitative measurement of enzyme activity.
Does neuronal activity affect NAPE metabolism?
Glutamate stimulation increases NAPE and N-acylethanolamine formation in cortical neurons, indicating activity-dependent regulation.
What diseases are associated with NAPE metabolism?
The pathway has been linked to obesity, hepatic steatosis, pain, and neuropsychiatric disorders through its role in endocannabinoid signaling [1,2,6].
Conclusion
GO:0070292, N-acylphosphatidylethanolamine metabolic process, describes a conserved lipid pathway that generates NAPE and its downstream signaling metabolites, including endocannabinoids [1,6]. The pathway is dynamically regulated by neuronal activity and dietary signals, and it has been implicated in metabolic disease, pain, and inflammation [2,8]. Continued research using genetic models, activity assays, and lipidomics will clarify its full physiological and pathological roles [3,4,5,7]. Targeting NAPE-metabolizing enzymes remains a promising strategy for therapeutic intervention.
References
- 1. Fowler CJ et al.. 2017. Endocannabinoid Turnover.. Adv Pharmacol 80:31-66 PMID: 28826539
- 2. Everard A et al.. 2019. Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosis.. Nat Commun 10(1):457 PMID: 30692526
- 3. Mock ED et al.. 2023. Fluorescence-Based NAPE-PLD Activity Assay.. Methods Mol Biol 2576:233-240 PMID: 36152191
- 4. Uyama T et al.. 2023. Assay of NAT Activity.. Methods Mol Biol 2576:213-224 PMID: 36152189
- 5. Chiu DC et al.. 2025. Photoaffinity Labeling Reveals a Role for the Unusual Triply Acylated Phospholipid N-Acylphosphatidylethanolamine in Lactate Homeostasis.. J Am Chem Soc 147(37):33386-33394 PMID: 40908803
- 6. Ueda N et al.. 2005. Endocannabinoid-related enzymes as drug targets with special reference to N-acylphosphatidylethanolamine-hydrolyzing phospholipase D.. Curr Med Chem 12(12):1413-22 PMID: 15974992
- 7. Estrada-Valencia R et al.. 2023. The Endocannabinoid System in Caenorhabditis elegans.. Rev Physiol Biochem Pharmacol 184:1-31 PMID: 34401955
- 8. Hansen HS et al.. 1995. Glutamate stimulates the formation of N-acylphosphatidylethanolamine and N-acylethanolamine in cortical neurons in culture.. Biochim Biophys Acta 1258(3):303-8 PMID: 7548201
